102 related articles for article (PubMed ID: 16533402)
21. Frequencies of HLA-DR3, -DR4, -B8 and -Bw62 in diabetic children diagnosed between 1960 and 1990.
Mäenpää A; Koskimies S; Scheinin T; Schlenzka A; Akerblom HK; Mäenpää J; Reunanen A; Kontiainen S
Diabetes Res; 1991 Apr; 16(4):159-63. PubMed ID: 1802481
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A
J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621
[TBL] [Abstract][Full Text] [Related]
23. Serological HLA class I alleles in Senegalese blood donors detected HBs Ag positive.
Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L; Dieye A
Immunol Lett; 2000 Nov; 74(3):229-32. PubMed ID: 11064107
[TBL] [Abstract][Full Text] [Related]
24. Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination.
Correll A; Tuettenberg A; Becker C; Jonuleit H
Exp Dermatol; 2010 Aug; 19(8):e213-21. PubMed ID: 20500773
[TBL] [Abstract][Full Text] [Related]
25. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
26. HLA class I haplotypes in families of children with coeliac disease.
Kedzierska A; Turowski G
Med Sci Monit; 2000; 6(2):336-41. PubMed ID: 11208333
[TBL] [Abstract][Full Text] [Related]
27. HLA-A, HLA-B and HLA-DRB1 allele and haplotype diversity among volunteer bone marrow donors from Croatia.
Grubic Z; Burek Kamenaric M; Mikulic M; Stingl Jankovic K; Maskalan M; Zunec R
Int J Immunogenet; 2014 Jun; 41(3):211-21. PubMed ID: 24762167
[TBL] [Abstract][Full Text] [Related]
28. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
[TBL] [Abstract][Full Text] [Related]
29. Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.
Gogas H; Kirkwood JM; Falk CS; Dafni U; Sondak VK; Tsoutsos D; Stratigos A; Markopoulos C; Pectasides D; Spyropoulou-Vlachou M
Cancer; 2010 Sep; 116(18):4326-33. PubMed ID: 20549830
[TBL] [Abstract][Full Text] [Related]
30. High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry.
Gourraud PA; Pappas DJ; Baouz A; Balère ML; Garnier F; Marry E
Hum Immunol; 2015 May; 76(5):381-4. PubMed ID: 25637665
[TBL] [Abstract][Full Text] [Related]
31. Allele and haplotype frequencies at human leukocyte antigen class I and II genes in Venezuela's population.
Del Pilar Fortes M; Gill G; Paredes ME; Gamez LE; Palacios M; Blanca I; Tassinari P
Ann Biol Clin (Paris); 2012; 70(2):175-81. PubMed ID: 22484528
[TBL] [Abstract][Full Text] [Related]
32. A novel HLA-B*55 allele, HLA-B*5514, found in a DNA sample derived from a bone marrow donor.
Witter K; Zahn R; McNicholas A; Volgger A; Albert ED
Tissue Antigens; 2005 May; 65(5):500-2. PubMed ID: 15853908
[TBL] [Abstract][Full Text] [Related]
33. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
34. Association of HLA phenotype with response to active specific immunotherapy of melanoma.
Mitchell MS; Harel W; Groshen S
J Clin Oncol; 1992 Jul; 10(7):1158-64. PubMed ID: 1607920
[TBL] [Abstract][Full Text] [Related]
35. Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application.
Mori M; Graves M; Milford EL; Beatty PG
Biol Blood Marrow Transplant; 1996 Oct; 2(3):134-44. PubMed ID: 9199756
[TBL] [Abstract][Full Text] [Related]
36. MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies.
Malkki M; Single R; Carrington M; Thomson G; Petersdorf E
Tissue Antigens; 2005 Aug; 66(2):114-24. PubMed ID: 16029431
[TBL] [Abstract][Full Text] [Related]
37. HLA-A, HLA-B and HLA-DRB1 haplotype frequencies in Piauí's volunteer bone marrow donors enrolled at the Brazilian registry.
Carvalho MG; Tsuneto LT; Moita Neto JM; Sousa LC; Sales Filho HL; Macêdo MB; Barroso JR; Pereira EM; Araújo AS; Silva AS; Monte SJ
Hum Immunol; 2013 Dec; 74(12):1598-602. PubMed ID: 23994585
[TBL] [Abstract][Full Text] [Related]
38. HLA class I polymorphism and the susceptibility to malignant melanoma.
Muto M; Ohmura A; Nakano J; Yamazaki N; Yamamoto A; Ishihara K; Sasazuki T; Asagami C
Tissue Antigens; 1996 May; 47(5):447-9. PubMed ID: 8795150
[No Abstract] [Full Text] [Related]
39. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
[TBL] [Abstract][Full Text] [Related]
40. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.
Luongo V; Pirozzi G; Caracò C; Errico S; de Angelis F; Celentano E; Paino F; Chiofalo MG; Luongo M; Mozzillo N; Lombardi ML
Tissue Antigens; 2004 Jul; 64(1):84-7. PubMed ID: 15191529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
